SOURCE: Quture, Inc.

August 23, 2011 08:00 ET

Quture/TCLN Announces Application Partnership With InterSystems

Company Pursuing Agreement on Leading Technology Platform

WEST PALM BEACH, FL--(Marketwire - Aug 23, 2011) - Techs Loanstar, Inc. (OTCQB: TCLN) (PINKSHEETS: TCLN) and Quture, Inc. ("Quture") immediately followed their merger with an announcement that they are aggressively seeking to develop their new "transformative" and "disruptive" tool to improve health care while reducing costs on the InterSystems Corporation ( integrated technology.

The Application Partnership Agreement signed between the parties is now the focus of a Demonstration Project that includes Keith Candiotti, M.D., Director of Clinical Research, Department of Anesthesiology, Jackson Memorial Hospital and University of Miami Medical School. The extensive intellectual property of Quture is embedded in the Company's soon-to-be announced product on the InterSystems platform. InterSystems and Quture hope to soon jointly announce the success of this Demonstration after its application with selected performance and outcomes measures by Dr. Candiotti.

The Demonstration will prove the use of electronic data integration and analytics to transform existing labor-intensive, anecdotal, and vital quality and risk management processes to rapid and enterprise-wide electronic processes.

"This is another big step forward in our development," said Landon Feazell, CEO of Quture. "The collaboration between Dr. Candiotti and Dr. Janice J. Ophoven, as previously announced, in using the incredible technology platform of InterSystems is a significant milestone."

InterSystems Ensemble® will be used for data integration to capture clinical data from any vendor's electronic medical records and software into the InterSystems CACHÉ® high performance object database. InterSystems integrated technology is aptly-suited to harness and support the power of Quture's intellectual property. Additionally the Demonstration will utilize InterSystems DeepSee™ for embedded real-time business intelligence capabilities package for health care enterprise management that is so desperately needed by physicians, clinicians, administration, boards and the quality and patient safety professionals in hospitals and physician groups in America and internationally.

Added Feazell: "It is truly remarkable that InterSystems' integrated technology is fully developed and deployed to satisfy our requirements and specifications. We believe we can solve the problems of disparate databases and silos of information that have limited our endeavors for over 35 years of clinical performance measurement in health care. This is a pivotal juncture in health care and its impact on the American economy and on the lives of patients and the professionals devoted to caring for them. We will be proud to introduce these new tools to accomplish our mission and to exceed and bring new capability to the extensive new federal and national mandates and standards."

About Quture

Quture, Inc., a Nevada corporation, is positioned to rapidly become the international standard in healthcare performance and outcomes measurement and analytics to accomplish its corporate mission. Quture provides healthcare organizations, insurers, government payers, and other stakeholders in the healthcare community with performance measurement tools and data sets. Industry experts agree that performance and outcomes measurement is the "transformative tool" to reduce medical cost and improve quality of care. Quture's management team has 35 years of experience and a long history of working with many of the nation's leading healthcare institutions as a leader and innovator in measuring clinical performance. Quture is now testing its revolutionary solution to effectively and efficiently measure clinical performance from multiple vendor databases.

Forward-Looking Statements

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law.

Contact Information

  • For Further Information Contact:
    Constellation Asset Advisors, Inc.
    Jens Dalsgaard
    +1 (415) 524-8500